Nelson Roberts Investment Advisors Has Decreased Its Novartis A G Spon Adr (NVS) Holding; NBT Bancorp Inc. (NBTB) Had 0 Analysts Last Week

November 14, 2017 - By Clifton Ray

Nelson Roberts Investment Advisors Llc decreased Novartis A G Spon Adr (NVS) stake by 99.4% reported in 2017Q2 SEC filing. Nelson Roberts Investment Advisors Llc sold 61,457 shares as Novartis A G Spon

Adr (NVS)’s stock rose 4.17%. The Nelson Roberts Investment Advisors Llc holds 373 shares with $31,000 value, down from 61,830 last quarter. Novartis A G Spon Adr now has $217.79B valuation. The stock rose 0.37% or $0.31 reaching $83.02. About 940,926 shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since November 14, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.

Among 5 analysts covering NBT Bancorp Inc (NASDAQ:NBTB), 0 have Buy rating, 0 Sell and 5 Hold. Therefore 0 are positive. NBT Bancorp Inc had 14 analyst reports since August 3, 2015 according to SRatingsIntel. On Thursday, January 7 the stock rating was initiated by Piper Jaffray with “Neutral”. The firm has “Hold” rating given on Tuesday, July 25 by Keefe Bruyette & Woods. The stock has “Neutral” rating by PiperJaffray on Thursday, June 8. The firm earned “Underweight” rating on Wednesday, November 16 by Piper Jaffray. The stock has “Hold” rating by Keefe Bruyette & Woods on Tuesday, October 3. Boenning & Scattergood maintained NBT Bancorp Inc. (NASDAQ:NBTB) on Tuesday, July 25 with “Sell” rating. The rating was maintained by Piper Jaffray with “Hold” on Thursday, July 13. Piper Jaffray maintained it with “Hold” rating and $35.0 target in Monday, October 23 report. The stock of NBT Bancorp Inc. (NASDAQ:NBTB) earned “Underweight” rating by PiperJaffray on Wednesday, November 16. On Tuesday, August 15 the stock rating was maintained by Boenning & Scattergood with “Hold”. See NBT Bancorp Inc. (NASDAQ:NBTB) latest ratings:

23/10/2017 Broker: Piper Jaffray Rating: Hold New Target: $35.0 Maintain
24/10/2017 Broker: Boenning & Scattergood Rating: Hold Maintain
03/10/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $38.0 Maintain
15/08/2017 Broker: Boenning & Scattergood Rating: Hold Maintain
25/07/2017 Broker: Piper Jaffray Rating: Hold New Target: $35.0000 Maintain
25/07/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $38.5000 Maintain
25/07/2017 Broker: Boenning & Scattergood Rating: Sell New Target: $35.0000 Maintain
13/07/2017 Broker: Piper Jaffray Rating: Hold New Target: $35.5000 Maintain
08/06/2017 Broker: PiperJaffray Old Rating: Underweight New Rating: Neutral Upgrade

Among 15 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 3 Sell and 7 Hold. Therefore 33% are positive. Novartis Ag had 33 analyst reports since July 28, 2015 according to SRatingsIntel. On Friday, April 1 the stock rating was downgraded by UBS to “Neutral”. The firm has “Neutral” rating by J P Morgan Chase Co given on Friday, June 16. On Monday, July 10 the stock rating was maintained by Cowen & Co with “Hold”. Argus Research initiated the shares of NVS in report on Tuesday, April 5 with “Hold” rating. Chardan Capital Markets initiated it with “Buy” rating and $95.0 target in Tuesday, September 20 report. The rating was maintained by Leerink Swann on Monday, October 23 with “Market Perform”. The firm has “Underperform” rating given on Wednesday, October 28 by Mainfirst. The firm has “Hold” rating given on Wednesday, August 9 by Cowen & Co. The company was downgraded on Tuesday, January 3 by JP Morgan. The stock of Novartis AG (ADR) (NYSE:NVS) has “Neutral” rating given on Friday, March 24 by JP Morgan.

Analysts await Novartis AG (ADR) (NYSE:NVS) to report earnings on January, 24. They expect $1.16 earnings per share, up 3.57% or $0.04 from last year’s $1.12 per share. NVS’s profit will be $3.04B for 17.89 P/E if the $1.16 EPS becomes a reality. After $1.29 actual earnings per share reported by Novartis AG (ADR) for the previous quarter, Wall Street now forecasts -10.08% negative EPS growth.

NBT Bancorp Inc. is a financial holding company. The company has market cap of $1.58 billion. The Firm conducts its business through NBT Bank, National Association and also through its other subsidiaries, which includes providing commercial banking and financial services to clients in its market area, including central and upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont and Portland, Maine area. It has a 18.98 P/E ratio. The Bank is a commercial bank, which provides a range of financial products to individuals, firms and municipalities.

Investors sentiment increased to 1.21 in 2017 Q2. Its up 0.01, from 1.2 in 2017Q1. It increased, as 13 investors sold NBT Bancorp Inc. shares while 34 reduced holdings. 15 funds opened positions while 42 raised stakes. 21.34 million shares or 1.18% less from 21.60 million shares in 2017Q1 were reported. State Board Of Administration Of Florida Retirement Sys invested in 50,396 shares. Salzhauer Michael stated it has 39,997 shares or 0.68% of all its holdings. Community Comml Bank Na owns 53,130 shares for 0.21% of their portfolio. Swiss Comml Bank accumulated 70,800 shares. Chemung Canal Trust holds 0.06% of its portfolio in NBT Bancorp Inc. (NASDAQ:NBTB) for 7,146 shares. Prudential Fincl owns 0% invested in NBT Bancorp Inc. (NASDAQ:NBTB) for 75,246 shares. Fenimore Asset Mngmt Incorporated holds 37,270 shares. The Georgia-based Invesco has invested 0% in NBT Bancorp Inc. (NASDAQ:NBTB). Texas Permanent School Fund holds 0.02% or 31,719 shares. Rhumbline Advisers, Massachusetts-based fund reported 87,851 shares. Biondo Investment Advsr Limited Com stated it has 0.06% of its portfolio in NBT Bancorp Inc. (NASDAQ:NBTB). Wells Fargo And Mn owns 43,930 shares. Mason Street Advsr Lc accumulated 10,713 shares or 0.01% of the stock. The Iowa-based Principal Financial Gp has invested 0.01% in NBT Bancorp Inc. (NASDAQ:NBTB). Eaton Vance Management stated it has 0% of its portfolio in NBT Bancorp Inc. (NASDAQ:NBTB).

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>